A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
Clinical trial NCT06255223 · RECRUITING
Trial details
- NCT number
- NCT06255223
- Sponsor
- Jinling Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-15
- Primary completion
- 2026-09-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.